K. Ziegler
About
In The Last Decade
K. Ziegler
48 papers receiving 910 citations
Peers
Comparison fields: 5 of 84
- Oncology 553
- Molecular Biology 352
- Surgery 169
- Pharmacology 163
- Pediatrics, Perinatology and Child Health 135
Countries citing papers authored by K. Ziegler
This map shows the geographic impact of K. Ziegler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Ziegler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Ziegler more than expected).
Fields of papers citing papers by K. Ziegler
This network shows the impact of papers produced by K. Ziegler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Ziegler. The network helps show where K. Ziegler may publish in the future.
Co-authorship network of co-authors of K. Ziegler
This figure shows the co-authorship network connecting the top 25 collaborators of K. Ziegler. A scholar is included among the top collaborators of K. Ziegler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Ziegler. K. Ziegler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | Hepatobiliary elimination of certain peptide-mimicking drugs: linear hydrophobic and hydrophilic renin-inhibitors and hydrophobic cyclopeptides. | 6 |
| 4 | 12 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 21 | |
| 10 | 5 | |
| 11 | 27 | |
| 12 | 5 | |
| 13 | 17 | |
| 14 | 21 | |
| 15 | 14 | |
| 16 | Photoaffinity labeling of membrane proteins from rat liver and pig kidney with cyclosporine diazirine. Involvement of binding to plasma membranes cytotoxic effects. | 9 |
| 17 | 160 | |
| 18 | 4 | |
| 19 | Molecular aspects of cytoprotection by modified somatostatins. | 5 |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.